ADMA Biologics's chart data is dated 2026-10-08. Recorded technical signals: MA aligned. There are 3 published signal records.
ADMA Biologics last closed at $10.33 (+1.87%) on 2026-10-08. Signals today: MA aligned. Listed on Nasdaq. Trailing 12 months PER is 14.1×. Its overall grade ranks 258 of 738 stocks in Healthcare.
About this company
ADMA Biologics last closed at $10.33 (+1.87%) on 2026-10-08. Signals today: MA aligned. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 258/738
Valuation grade F
Related stocks
- GrifolsCompetitor
면역글로불린·혈장유래 치료제 분야의 주요 경쟁사
- TakedaCompetitor
면역글로불린/혈장유래 제제 시장에서 경쟁하는 글로벌 제약사
- CSLCompetitor
혈장분획 및 면역글로불린 제품의 대표 경쟁사
About ADMA Biologics
- What technical signals does ADMA Biologics (ADMA) have?
- ADMA Biologics current technical signals: MA alignment (score 0.49).
- Is ADMA Biologics a cup-and-handle pattern?
- No. ADMA Biologics has no valid Cup signal right now.
- What published figures are available for ADMA Biologics?
- Market cap: $2.46B. Trailing 12 months PER: 14.1×. Latest quarter PBR: 5.83×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about ADMA Biologics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.